BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36344176)

  • 1. Prostate Cancer: Update on Grading and Reporting.
    Baraban E; Epstein J
    Surg Pathol Clin; 2022 Dec; 15(4):579-589. PubMed ID: 36344176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
    Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
    Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.
    Epstein JI; Egevad L; Amin MB; Delahunt B; Srigley JR; Humphrey PA;
    Am J Surg Pathol; 2016 Feb; 40(2):244-52. PubMed ID: 26492179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The updated grading system of prostate carcinoma: an inter-observer agreement study among general pathologists in an academic practice.
    Al Nemer AM; Elsharkawy T; Elshawarby M; Al-Tamimi D; Kussaibi H; Ahmed A
    APMIS; 2017 Nov; 125(11):957-961. PubMed ID: 28913842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
    Epstein JI; Amin MB; Reuter VE; Humphrey PA
    Am J Surg Pathol; 2017 Apr; 41(4):e1-e7. PubMed ID: 28177964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of paneth cell-like neuroendocrine differentiation in adenocarcinoma of the prostate.
    Tamas EF; Epstein JI
    Am J Surg Pathol; 2006 Aug; 30(8):980-5. PubMed ID: 16861969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reporting Trends, Practices, and Resource Utilization in Neuroendocrine Tumors of the Prostate Gland: A Survey among Thirty-Nine Genitourinary Pathologists.
    Mohanty SK; Lobo A; Williamson SR; Shah RB; Trpkov K; Varma M; Sirohi D; Aron M; Kandukari SR; Balzer BL; Luthringer DL; Ro J; Osunkoya AO; Desai S; Menon S; Nigam LK; Sardana R; Roy P; Kaushal S; Midha D; Swain M; Ambekar A; Mitra S; Rao V; Soni S; Jain K; Diwaker P; Pattnaik N; Sharma S; Chakrabarti I; Sable M; Jain E; Jain D; Samra S; Vankalakunti M; Mohanty S; Parwani AV; Sancheti S; Kumari N; Jha S; Dixit M; Malik V; Arora S; Munjal G; Gopalan A; Magi-Galluzzi C; Dhillon J
    Int J Surg Pathol; 2023 Sep; 31(6):993-1005. PubMed ID: 35946087
    [No Abstract]   [Full Text] [Related]  

  • 8. A grading dilemma; Gleason scoring system: Are we sufficiently compatible? A multi center study.
    Dere Y; Çelik ÖI; Çelik SY; Ekmekçi S; Evcim G; Pehlivan F; Ağalar A; Deliktaş H; Çulhacı N
    Indian J Pathol Microbiol; 2020 Feb; 63(Supplement):S25-S29. PubMed ID: 32108622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interobserver reproducibility of Gleason grading of prostatic adenocarcinoma among general pathologists.
    Singh RV; Agashe SR; Gosavi AV; Sulhyan KR
    Indian J Cancer; 2011; 48(4):488-95. PubMed ID: 22293266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential Updates in Grading, Morphotyping, Reporting, and Staging of Prostate Carcinoma for General Surgical Pathologists.
    Paner GP; Gandhi J; Choy B; Amin MB
    Arch Pathol Lab Med; 2019 May; 143(5):550-564. PubMed ID: 30865487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large-Gland Proliferations of the Prostate.
    Iczkowski KA
    Surg Pathol Clin; 2018 Dec; 11(4):687-712. PubMed ID: 30447836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outlook of Gleason score in prostate carcinoma and correlation with PSA levels: A study in a tertiary care hospital.
    Rani E; Nibhoria S; Nagpal N
    J Cancer Res Ther; 2023; 19(5):1305-1310. PubMed ID: 37787299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of interobserver reproducibility of Gleason grading of prostatic carcinoma in Japan and the United States.
    Oyama T; Allsbrook WC; Kurokawa K; Matsuda H; Segawa A; Sano T; Suzuki K; Epstein JI
    Arch Pathol Lab Med; 2005 Aug; 129(8):1004-10. PubMed ID: 16048389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer: from Gleason scoring to prognostic grade grouping.
    Montironi R; Santoni M; Mazzucchelli R; Burattini L; Berardi R; Galosi AB; Cheng L; Lopez-Beltran A; Briganti A; Montorsi F; Scarpelli M
    Expert Rev Anticancer Ther; 2016; 16(4):433-40. PubMed ID: 27008205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of Paneth cell-like differentiation in prostatic adenocarcinoma: a retrospective cohort study of 80 cases.
    Salles DC; Mata DA; Epstein JI
    Hum Pathol; 2020 Aug; 102():7-12. PubMed ID: 32445653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the Gleason grading system for prostate cancer: results of an international consensus conference of urologic pathologists.
    Epstein JI; Allsbrook WC; Amin MB; Egevad LL
    Adv Anat Pathol; 2006 Jan; 13(1):57-9. PubMed ID: 16462155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variant of prostatic adenocarcinoma with Paneth cell-like neuroendocrine differentiation readily misdiagnosed as Gleason pattern 5.
    So JS; Gordetsky J; Epstein JI
    Hum Pathol; 2014 Dec; 45(12):2388-93. PubMed ID: 25277321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of Ets-related gene-transcriptional factor in adenocarcinoma prostate and its correlation with Gleason score.
    Mannan R; Bhasin TS; Manjari M; Singh G; Bhatia PK; Sharma S
    Indian J Pathol Microbiol; 2016; 59(4):489-495. PubMed ID: 27721279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
    Herawi M; Epstein JI
    Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of prostatic adenocarcinoma Gleason 5 and intraductal carcinoma of the prostate with tumor necrosis. A morphometric study.
    Acosta AM; Vormittag E; Al Rasheed MRH; Sharif A; Mon KS; Kajdacsy-Balla A; Mohapatra G
    Pathol Res Pract; 2018 Oct; 214(10):1681-1685. PubMed ID: 30195638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.